10-Q: Selectis Health Q1 2026 Financial Results
Quarterly Report
Selectis Health reports a net income of $6.5 million for Q1 2026, driven primarily by asset sales, despite ongoing going concern uncertainties.
Summary
- Reported net income of $6.5 million for the three months ended March 31, 2026, compared to a net loss of $0.66 million in the same period of 2025.
- Total revenue for Q1 2026 was $7.29 million, down from $10.49 million in Q1 2025, primarily due to the sale of healthcare facilities.
- Recognized a gain on the sale of assets of $8.9 million during the quarter.
- Working capital deficiency remains at $6.5 million as of March 31, 2026.
- Total assets decreased to $30.01 million from $32.58 million at year-end 2025.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mixed result; while the asset sales provided a one-time cash infusion and net income, the underlying business remains loss-making and faces significant going concern risks.
Positives
- Significant net income of $6.5 million achieved in Q1 2026.
- Successful divestiture of non-core assets, resulting in an $8.9 million gain.
- Reduction in total liabilities from $38.79 million at year-end 2025 to $29.75 million as of March 31, 2026.
- Management fee revenue stream initiated, contributing $107,441 in the quarter.
Negatives
- Healthcare revenue declined by 32% year-over-year due to facility sales.
- Operating loss of $1.26 million for the quarter.
- Interest expense increased by 70% to $0.92 million compared to Q1 2025.
- Material weakness in internal controls over financial reporting identified.
Risks
- Substantial doubt exists regarding the ability to continue as a going concern due to historical losses and working capital deficiency.
- Dependence on future asset sales and capital raises to maintain liquidity.
- Exposure to potential legal claims and regulatory scrutiny inherent in the senior care industry.
- Material weakness in internal controls could lead to inaccurate financial reporting.
Future Outlook
The company plans to improve liquidity through facility sales, controlling operating expenses, and seeking additional capital via debt or equity securities. Management acknowledges that these actions are necessary to address going concern doubts.
Management Comments
- Management believes that the financial statements present fairly the financial position despite identified material weaknesses.
- The company is implementing a multi-level review process in 2026 to address internal control deficiencies.
Industry Context
StockSavvy.ai notes that the senior care industry is currently undergoing significant consolidation and asset rationalization. Selectis Health's strategy of divesting facilities to pay down debt is a common trend among smaller operators facing high interest costs and regulatory pressures.
Comparison to Industry Standards
- The company's reliance on asset sales to fund operations is typical for distressed healthcare REITs or operators.
- The 13% interest rate on senior secured notes is significantly higher than market benchmarks for institutional-grade healthcare real estate financing.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Remediation | Plan to implement multi-level review of accounts and reconciliations. | 2026 | Intended to address material weakness in financial reporting. |
Legal Proceedings
- The company is subject to routine claims of negligence and professional liability related to patient care, which are generally covered by insurance.
Related Party Transactions
- Historical senior secured notes included significant portions held by related parties, though these are being actively paid down.
Stakeholder Impact
- Shareholders benefit from the reduction in debt and improved equity position, but face dilution risk from potential future capital raises.
- Creditors see improved liquidity from asset sales, though going concern risk persists.
Next Steps
- Implementation of multi-level review processes for financial reporting.
- Continued efforts to improve occupancy and Medicaid reimbursement rates.
- Ongoing evaluation of potential asset sales to generate liquidity.
Key Dates
| Date | Description |
|---|---|
| 2026-01-01 | Start of the reporting period. |
| 2026-01-31 | Closing of the sale of two Georgia facilities. |
| 2026-03-05 | Execution of letter of intent for May 2026 asset sale. |
| 2026-03-31 | End of the reporting period. |
| 2026-05-01 | Closing of the sale of two additional Georgia facilities. |
| 2026-05-20 | Date of common stock outstanding count. |
| 2026-05-22 | Filing date of the 10-Q report. |
Recommendation
holdThe company is in a precarious financial position despite the recent gain on asset sales. A 'hold' is appropriate until there is evidence of sustainable operational profitability and a resolution to the going concern uncertainty.
Keywords
Selectis Health, Healthcare Real Estate, Skilled Nursing, Asset Divestiture, Going Concern, 10-Q
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.